Researched technical guides for pharmaceutical API procurement, quality standards, and therapeutic applications. Each article is fact-checked against pharmacopoeia monographs, FDA databases, and published clinical literature.
Comprehensive guide covering UDCA chemistry, mechanism of action, clinical applications (PBC, gallstone dissolution), quality standards, sourcing from China, and pricing. Includes USP vs EP comparison table and clinical dose reference.
Related: UDCA Product PageCholesterol gallstone biochemistry, UDCA dissolution mechanism, 8-10 mg/kg/day dosing protocol, patient selection criteria, efficacy data (Gleeson 1990, 126 patients), and recurrence prevention.
FDA-approved PBC first-line at 13-15 mg/kg/day with landmark trial references (Poupon 1991, Lindor 1994). PSC controversy, NASH experimental status, ICP in pregnancy.
Detailed USP vs EP monograph comparison with 12-row specification table. HPLC assay, impurity limits, residual solvents (ICH Q3C), heavy metals, CoA review guide, and CEP significance.
11-parameter comparison table. Regulatory status (FDA drug vs supplement), clinical evidence, cost, availability, and procurement decision framework for pharma vs supplement manufacturers.
Dose-dependent diarrhea (~25%), contraindications (calcified gallstones, biliary obstruction), drug interactions (bile acid sequestrants, aluminum antacids), Pregnancy Category B.
GMP verification, DMF/CEP filing check, audit checklist, CoA review priorities, 6 red flags, MOQ (25-50 kg), lead times (4-12 weeks), logistics, and payment terms.
Aminoglycoside antibiotic (Mason 1961). Mechanism, antibacterial spectrum, poultry CRD treatment, lincomycin combination, safety vs other aminoglycosides, FDA VMF & CEP compliance.
Related: Spectinomycin Product PageFDA-approved (NADA #038-661, 1969). Mycoplasma gallisepticum CRD control. Drinking water protocols, day-old chick injection, feed-grade vs water-soluble comparison.
Lincospectin (禽利高/易力能). FDA ANADA #200-407. 40g spectinomycin + 20g lincomycin/100g. Drinking water 0.5-0.8g/L × 3-5 days. Day-old chick injection 2000-3000/bottle.
VMF 005884, CEP 2024-135-REV 00, GMP per ICH Q7. DMF vs VMF vs CEP comparison. Documentation package for EU/US market access.
5-aminoglycoside comparison table. Oral absorption, injection safety, nephrotoxicity, ototoxicity, antibacterial spectrum, and key veterinary indications.
Taurine conjugate of UDCA (CAS 14605-22-2, MW 499.7). ER stress reduction, anti-apoptotic mechanisms. Clinical evidence in liver, neurological (ALS, Alzheimer, Parkinson), and metabolic conditions. TUDCA vs UDCA comparison.
Related: UDCA Complete GuideClinical evidence across liver (ALT/AST reduction in 3-month trial), neurological (ALS pilot: 1g BID well-tolerated, AD/Parkinson preclinical), and metabolic domains.
OTC supplement market overview. Capsules vs powders vs sublingual. Label reading, purity verification, third-party testing, and sports nutrition applications.
Most common: diarrhea (dose-dependent). Contraindications (biliary obstruction). Limited long-term data beyond 1 year. Drug interaction considerations.
Standard supplement: 250-500mg/day. Neurological protocols: 1000-1500mg/day (ALS trial: 1g BID). How to take, overdose ceiling, and physician consultation advisory.
Hepatoprotection mechanisms, PBC/PSC/ICP evidence, NAFLD preclinical data, and comparison with UDCA for liver indications.
Chemical differences (taurine conjugation), FDA status, bioavailability, blood-brain barrier penetration, clinical evidence level, cost comparison, and decision framework.
Supplement-grade vs pharmaceutical-grade TUDCA, quality parameters, supplier verification, red flags, MOQ expectations, and Chinese supplier landscape.
Six-step procurement process. Supplier identification (B2B platforms, CPHI, FDA DMF database), documentation requests, audit protocols, sample testing, negotiation, trial orders. Regulatory terms (DMF, CEP, ASMF, JDMF).
Comprehensive reference for pharmacopoeia standards (USP, EP, BP, CP, FCC), certifications (GMP, CEP, DMF, VMF), quality terms (ICH Q3C, CoA, MSDS), therapeutic categories, and trade terminology.